MEGAN OKUDA: Open Payments
NPI 1275165607 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$870 in 41 payments from 20 companies in 2025. Trend: 2023 $1,229 · 2024 $1,282 · 2025 $870
Food & beverage: $870
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $182 |
| Lilly USA, LLC | 4 | $83 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| Boston Scientific Corporation | 1 | $54 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| PFIZER INC. | 3 | $52 |
| Tris Pharma Inc | 2 | $48 |
| Exact Sciences Corporation | 2 | $38 |
| Collegium Pharmaceutical, Inc. | 2 | $38 |
| Merck Sharp & Dohme LLC | 1 | $27 |
Products named: VRAYLAR, MOUNJARO, AMS 700, UBRELVY, Dyanavel XR, Jornay PM, SHINGRIX, AIRSUPRA.
Industry payments across NC — which companies pay providers there.
